<SEC-DOCUMENT>0000724910-22-000006.txt : 20220202
<SEC-HEADER>0000724910-22-000006.hdr.sgml : 20220202
<ACCEPTANCE-DATETIME>20220202161415
ACCESSION NUMBER:		0000724910-22-000006
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20060101
ITEM INFORMATION:		Entry into a Material Definitive Agreement
FILED AS OF DATE:		20220202
DATE AS OF CHANGE:		20220202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NVE CORP /NEW/
		CENTRAL INDEX KEY:			0000724910
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				411424202
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-12196
		FILM NUMBER:		22583776

	BUSINESS ADDRESS:	
		STREET 1:		11409 VALLEY VIEW ROAD
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344
		BUSINESS PHONE:		9528299217

	MAIL ADDRESS:	
		STREET 1:		11409 VALLEY VIEW ROAD
		CITY:			EDEN PRAIRIE
		STATE:			MN
		ZIP:			55344

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PREMIS CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>NVE-ABT_AMENDMENT-8_2022_8K.htm
<DESCRIPTION>CURRENT REPORT ON FORM 8-K (AMENDMENT NO. 7)
<TEXT>
<p align="center"><font face="Times New Roman, Times, serif" size="5"><b>UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION</b></font><b><font face="Times New Roman, Times, serif" size="2"><br>
Washington, D.C.&nbsp;&nbsp;20549</font></b></p>
<p align="center"><b><font face="Times New Roman, Times, serif" size="5">FORM
8-K/A</font> <font face="Times New Roman, Times, serif" size="3"><br>
(Amendment No. 7)</font></b></p>
<p align="center"><b><font face="Times New Roman, Times, serif" size="3">CURRENT REPORT<br>
</font></b><font face="Times New Roman, Times, serif" size="3"><b>Pursuant to
Section 13 OR 15(d) of The Securities Exchange Act of 1934</b></font></p><p><font face="Times New Roman, Times, serif" size="2"><br>
Date of Report (Date of earliest event reported)&nbsp;&nbsp;<b><u>January&nbsp;1,
2006</u></b><br>
</font></p><div align="center"><b><font size="6" face="Arial, Helvetica, sans-serif"><img src="nve-logo.gif" width="276" height="55" alt="NVE Logo"><br>
NVE Corporation</font></b><font face="Times New Roman, Times, serif" size="2"><br>
(Exact name of registrant as specified in its charter)</font></div><font face="Times New Roman, Times, serif" size="2">
<div align="center">
<p>&nbsp;</p></div></font>
<div align="center"></div><table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="33%">
<p align="center"><font face="Times New Roman, Times, serif"><b><font size="2"><u>Minnesota</u></font></b></font></p></td><td width="33%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>000-12196</u>
</b></font></div></td><td>
<p align="center"><b><font size="2" face="Times New Roman"><u>41-1424202</u></font></b></p></td></tr>
<tr>
<td>
<p align="center"><font size="2" face="Times New Roman, Times, serif">(State
or other jurisdiction of incorporation)</font></p></td><td>
<div align="center"><font face="Times New Roman, Times, serif" size="2">(Commission File Number) </font></div></td><td>
<div align="center"><font size="2" face="Times New Roman, Times, serif">(IRS Employer Identification No.)</font></div></td></tr>
</table><br>
<br>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td rowspan="2" width="25%"></td><td width="50%">
<p align="center"><font size="2"><b><u>11409 Valley View Road, Eden Prairie,
Minnesota</u></b></font></p></td><td>
<p align="center"><font size="2"><b><font face="Times New Roman" ><u>55344</u></font></b></font></p></td></tr>
<tr>
<td width="50%">
<p align="center"><font size="2" face="Times New Roman, Times, serif">(Address of principal executive offices)</font></p></td><td>
<p align="center"><font size="2">(Zip Code)</font></p></td></tr>
</table><br>
<font size="2" face="Times New Roman, Times, serif">Registrant&#146;s telephone
number, including area code <b><u>(952) 829-9217</u></b><br>
<br>
<div align="center"><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><br>
(Former name or former address, if changed since last report.)</div>
<br>
</font><font style="font-size: 10pt; font-family: Times New Roman">Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):<br>
<br>
[&nbsp;&nbsp;] Written communications pursuant to Rule 425 under the Secu'rities
Act (17 CFR 230.425)<br>
<br>
[&nbsp;&nbsp;] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)<br>
<br>
[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))<br>
<br>
[&nbsp;&nbsp;] Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))<br>
&nbsp; <br>
Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this
chapter).<br>
&nbsp;<br>
<div align="right">Emerging&nbsp;growth&nbsp;company&nbsp;&nbsp;[&nbsp;&nbsp;]</div>
<br>
If an emerging growth company, indicate by check mark if the registrant has elected
not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange
Act.&nbsp;&nbsp;[&nbsp;&nbsp;]&nbsp;<br>
&nbsp;<br>
Securities registered pursuant to Section 12(b) of the Act:<br>
</font>
<table cellpadding="0" cellspacing="0" width="100%">
<tr align="center">
<td width="37%"><u><font size="2" face="Times New Roman, Times, serif">Title of
each class</font></u></td>
<td width="25%"><u><font size="2" face="Times New Roman, Times, serif">Trading
symbol(s)</font></u></td>
<td><u><font size="2" face="Times New Roman, Times, serif">Name of each exchange
on which registered</font></u></td>
</tr>
<tr align="center">
<td width="33%"><b><font size="2" face="Times New Roman, Times, serif">Common
Stock, $0.01 par value</font></b></td>
<td><b><font size="2" face="Times New Roman, Times, serif">NVEC</font></b></td>
<td><b><font size="2" face="Times New Roman, Times, serif">The NASDAQ Stock Market,
LLC</font></b></td>
</tr>
</table>
<font size="2">&nbsp;<br>
</font>
<DIV STYLE="page-break-after: always;"><HR></DIV>
<font face="Times New Roman, Times, serif" size="2"><b>Explanatory Note</b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Amendment No. 7 to Form 8-K is being filed
to disclose a eighth amendment to our Supplier Partnering Agreement dated January&nbsp;3,
2006 by and between Pacesetter,&nbsp;Inc., now a subsidiary of Abbott Laboratories
(&#147;Abbott&#148;), and us, as amended by Amendment No.&nbsp;1 to the Agreement
dated September&nbsp;6, 2007, Amendment No.&nbsp;2 dated December&nbsp;15, 2009,
Amendment No.&nbsp;3 dated September&nbsp;13, 2010, Amendment No.&nbsp;4 dated
February&nbsp;1, 2011, Amendment No.&nbsp;5 dated April&nbsp;20, 2016, Amendment
No.&nbsp;6 dated December&nbsp;18, 2020, and Amendment No.&nbsp;7 dated April&nbsp;30,
2021.<br>
<br>
<br>
<b>Item 1.01. Entry into a Material Definitive Agreement.</b><br>
<br>
<b><i>General Information</i></b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We supply products to Abbott under the Supplier
Partnering Agreement as amended.<br>
<br>
<b><i>Description of the Terms and Conditions of the Amendment</i></b><br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On February&nbsp;1, 2022, we executed Amendment
No.&nbsp;8 to the Supplier Partnering Agreement, which
extends the Agreement term through December&nbsp;31, 2022 and amends pricing.
The Amendment is filed as Exhibit 10.10 to this Current Report on Form 8-K/A.
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
</font>
<DIV STYLE="page-break-after: always;">
<DIV STYLE="width: 100%; text-align: center;"><font face="Times New Roman, Times, serif" size="2">2</FONT></DIV>
<HR>
</DIV>
<font face="Times New Roman, Times, serif" size="2">
<div align="center"><b>SIGNATURE</b><br>
<br>
</div>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.<br>
&nbsp;
</font>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td width="33%" valign="top"> <font face="Times New Roman, Times, serif" size="2">Date&nbsp;&nbsp;<b><u>February
2, 2022</u></b></font></td>
<td align="center" width="34%"><font face="Times New Roman, Times, serif" size="2"><b><u>NVE CORPORATION<br>
</u></b>(Registrant)<br>
<br>
<u>&nbsp;/s/&nbsp;DANIEL&nbsp;A.&nbsp;BAKER</u><br>
Daniel A. Baker<br>
President &amp; Chief Executive Officer</font></td>
<td width="33%"></td></tr>
</table>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p align="center"><DIV STYLE="page-break-after: always;">
<DIV STYLE="width: 100%; text-align: center;"><font face="Times New Roman, Times, serif" size="2">3</FONT></DIV>
<HR>
</DIV>
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b>INDEX TO EXHIBITS</b><br></font></div>
<br>
<table width="100%" border="0" cellspacing="0" cellpadding="0">
<tr>
<td width="1%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Exhibit&nbsp;#</u></b></font></div>
</td>
<td width="88%">
<div align="center"><font face="Times New Roman, Times, serif" size="2"><b><u>Description</u></b></font></div>
</td>
</tr>
<tr>
<td colspan="2"><font face="Times New Roman, Times, serif" size="2">&nbsp;</font></td>
</tr>
<tr>
<td valign="top" bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.1</font></td>
<td bgcolor="#ccdaef" valign="top"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491005000021/sjm-ind05.txt"><font size="2">Indemnification
Agreement by and between Pacesetter, Inc., a St. Jude Medical Company, d.b.a.
St. Jude Medical Cardiac Rhythm Management Division, and the company (incorporated
by reference to the Form 8-K filed September&nbsp;27, 2005).</font></a><br>
&nbsp;</td>
</tr>
<tr>
<td valign="top"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.2+</font></td>
<td><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491006000003/sjm-agmt.txt">Supplier
Partnering Agreement by and between St.&nbsp;Jude and the company (incorporated
by reference to the <font style="white-space: nowrap;">Form 8-K</font> filed January&nbsp;4,
2006).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.3+</font></td>
<td bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491007000015/sjm-a1.htm">Amendment
No. 1 to Supplier Partnering Agreement between St.&nbsp;Jude and the company (incorporated
by reference to the Form 8-K/A filed September 10, 2007).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.4+</font></td>
<td><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491009000021/sjm-a2.htm">Amendment
No. 2 to Supplier Partnering Agreement between St.&nbsp;Jude and the company (incorporated
by reference to the Form 8-K/A filed December&nbsp;18, 2009).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.5+</font></td>
<td bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491010000022/sjm-a3.htm">Amendment
No. 3 to Supplier Partnering Agreement between St. Jude and the company (incorporated
by reference to the Form 8-K/A filed September&nbsp;16, 2010).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.6</font></td>
<td><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491011000006/sjm-a4.htm">Amendment
No. 4 to Supplier Partnering Agreement between St.&nbsp;Jude and the company (incorporated
by reference to the Form 8-K/A filed February&nbsp;7, 2011).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.7</font></td>
<td bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif"><a href="http://www.sec.gov/Archives/edgar/data/724910/000072491016000048/stj-a5.htm">Amendment
No. 5 to Supplier Partnering Agreement between St.&nbsp;Jude and the company (incorporated
by reference to the Form 8-K/A filed April&nbsp;21, 2016).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.8</font></td>
<td><font size="2" face="Times New Roman, Times, serif"><a href="https://www.sec.gov/Archives/edgar/data/724910/000072491020000041/stj-a6.htm">Amendment
No. 6 to Supplier Partnering Agreement between Abbott and the company (incorporated
by reference to the Form 8-K/A filed December&nbsp;21, 2020).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.9</font></td>
<td bgcolor="#ccdaef"><font size="2" face="Times New Roman, Times, serif"><a href="https://www.sec.gov/Archives/edgar/data/724910/000072491021000008/stj-a7.htm">Amendment
No. 7 to Supplier Partnering Agreement between Abbott and the company (incorporated
by reference to the Form 10-K filed May&nbsp;5, 2021).</a><br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top"><font size="2" face="Times New Roman, Times, serif">&nbsp;&nbsp;10.10*</font></td>
<td><font size="2" face="Times New Roman, Times, serif"><a href="abt-a8.htm">Amendment
No. 8 to Supplier Partnering Agreement between Abbott and the company (filed with
this Current Report on Form 8-K/A).</a><br>
&nbsp;</font></td>
</tr>
</table>
<font face="Times New Roman, Times, serif" size="2">&nbsp;<br>
+Confidential portions of this exhibit were deleted and filed separately with
the SEC under a request for confidential treatment pursuant to Rule 24b-2 or Rule
406.<br>
<br>
*Certain confidential portions of this exhibit have been redacted pursuant to
Item 601(b)(10)(iv) of Regulation S-K. The omitted information is (i) not material
and (ii) would likely cause us competitive harm if publicly disclosed. We agree
to furnish supplementally an unredacted copy of the exhibit to the Securities
and Exchange Commission on its request. </font>
<p>&nbsp;</p>
<p align="center"><font face="Times New Roman, Times, serif" size="2"><br>4</font>
<hr>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>2
<FILENAME>abt-a8.htm
<DESCRIPTION>AMENDMENT NO. 8 TO PARTNERING AGREEMENT BETWEEN ABBOTT AND THE COMPANY
<TEXT>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br>
<div align="center"><b>AMENDMENT NO. 8<br>
TO<br>
SUPPLIER PARTNERING AGREEMENT</b>&nbsp;<br>&nbsp;<br></div>
<div style="text-indent: 48pt">THIS AMENDMENT TO SUPPLIER PARTNERING AGREEMENT
(this &#147;Amendment&#148;), dated as of November&nbsp;10, 2021, (the &#147;Amendment
Effective Date&#148;) is made and entered into by and between Pacesetter, Inc.,
with offices at 15900&nbsp;Valley View Court, Sylmar, California, 91342 (&#147;Buyer&#148;),
and NVE Corporation, with a principal place of business at 11409&nbsp;Valley View
Rd, Eden Prairie, Minnesota, 553443617 (&#147;Seller&#148;).<br>
&nbsp;</div>
<div align="center">RECITALS</div>
&nbsp;<br></font>
<table border="0" cellspacing="00" cellpadding="0" width="100%">
<tr>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">A.</font></td>
<td><font style="font-size: 12pt; font-family: Times New Roman">Buyer and Seller
are parties to that certain SUPPLIER PARTNERING AGREEMENT with an effective date
of January&nbsp;1, 2006; Amendment No.&nbsp;1 with an effective date of September&nbsp;6, 2007;
Amendment No.&nbsp;2 with an effective date of December&nbsp;15, 2009; Amendment No.&nbsp;3 with
an effective date of September&nbsp;13, 2010; Amendment No.&nbsp;4 with an effective date
of February&nbsp;1, 2011; Amendment No.&nbsp;5 with an effective date of April&nbsp;20, 2016;
Amendment No.&nbsp;6 with an effective date of December&nbsp;16, 2020; and Amendment No.&nbsp;7
with an effective date of April&nbsp;12, 2021 (collectively the &#147;Agreement&#148;).<br>
&nbsp;</font></td>
</tr>
</table>
<table border="0" cellspacing="00" cellpadding="0" width="100%">
<tr>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">B.</font></td>
<td valign="top"><font style="font-size: 12pt; font-family: Times New Roman">Buyer
and Seller now wish to amend the terms of Agreement as set forth in this Amendment.<br>
&nbsp;<br>
NOW, THEREFORE, Buyer and Seller agree to amend the Agreement as follows:<br>
&nbsp;</font></td>
</tr>
</table>
<table border="0" cellspacing="00" cellpadding="0" width="100%">
<tr>
<td valign="top" width="96">&nbsp;</td>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">1.</font></td>
<td colspan="3"><font style="font-size: 12pt; font-family: Times New Roman">Section
1, <u>Term of Agreement</u>, is hereby deleted and replaced with the following<br>
&nbsp;</font></td>
</tr>
<tr>
<td>&nbsp;</td>
<td>&nbsp; </td>
<td valign="top" width="48"><font style="font-size: 12pt; font-family: Times New Roman">1.</font></td>
<td colspan="2"><font style="font-size: 12pt; font-family: Times New Roman"><u>Term
of </u>Agreement. This Agreement begins on January&nbsp;1, 2006 and will remain
in force through December&nbsp;31, 2022, unless terminated earlier.<br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" width="96">&nbsp;</td>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">2.</font></td>
<td colspan="3" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">Section
10.8, Compliance with Supplier Guidelines, is hereby added with the following:<br>&nbsp;<br>
10.8&nbsp;&nbsp;&nbsp;&nbsp;<u>Compliance with Supplier Guidelines.</u> Buyer
is committed to supporting and applying the fundamental principles of human rights,
labor, environmental protection, and anti-corruption to ensure Buyer&#146;s and
our suppliers&#146; long-term business success, as well as improving lives around
the world. Supplier has read and agrees to comply with the values represented
in Buyer&#146;s Supplier Guidelines found at http://www.abbott.com/partners/suppliers.html,
as in effect from time to time (&#147;Guidelines&#148;). At Buyer&#146;s request,
Supplier shall (i)&nbsp;provide information and access to Buyer (or applicable
Buyer Affiliate, or their delegated third-party advisors) for the purposes of
confirming Supplier&#146;s compliance with the Guidelines; and (ii)&nbsp;use commercial
reasonable efforts to remediate identified issues and to report its corrective
actions. In the event of a conflict between this Agreement and the Guidelines,
the terms of this Agreement will prevail.<br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" width="96">&nbsp;</td>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">3.</font></td>
<td colspan="3" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">Attachment
1 is hereby amended to reflect a 2022 price of the following:<br>
&nbsp;<br>
Part Number 1071000-001 increase from current price of $** to $**; Part Number
100101124 increase from current price of $** to $**. These increases are effective
with all shipments made after December&nbsp;1, 2021.<br>
&nbsp;</font></td>
</tr>
<tr>
<td valign="top" width="96">&nbsp;</td>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">4.</font></td>
<td colspan="3" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">If
any provisions of this Amendment and the Agreement conflict, the provisions of
this Amendment shall prevail. Except as specifically amended herein, all terms
and conditions of the Agreement shall remain in full force and effect.<br>
&nbsp;</font></td>
</tr>
</table>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br>
</font>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td><font style="font-size: 12pt; font-family: Times New Roman">9025.3 - NVE Corporation
- Supply (Direct) Amended</font></td>
<td align="right"><font style="font-size: 12pt; font-family: Times New Roman">Page&nbsp;1&nbsp;of&nbsp;2</font></td>
</tr>
</table>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br></font>
<DIV STYLE="page-break-after: always;"><HR></DIV>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br></font>
<table border="0" cellspacing="00" cellpadding="0" width="100%">
<tr>
<td valign="top" width="96">&nbsp;</td>
<td width="48" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">5.</font></td>
<td colspan="3" valign="top"><font style="font-size: 12pt; font-family: Times New Roman">Each
party represents that it has authority to enter into this Amendment. This Amendment
may be executed in counterparts, each of which for all purposes shall be deemed
an original, and all of which constitute, collectively, one agreement. Facsimile
or electronically transmitted signatures shall be deemed effective as originals.</font></td>
</tr>
</table>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br>
The parties have caused this Amendment to be signed by their duly authorized representatives,
effective as of the Amendment Effective Date.<br>
&nbsp;<br>
</font>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td valign="top"><font style="font-size: 12pt; font-family: Times New Roman">Pacesetter, Inc.<br>
&nbsp;<br>&nbsp;<br>
By:&nbsp;<u>&nbsp;/s/&nbsp;JONATHAN&nbsp;HARRINGTON&nbsp;</u><br>
&nbsp;<br>
Name: <u>&nbsp;Jonathan&nbsp;Harrington&nbsp;</u></font><br>
&nbsp;<br>
Title:&nbsp;<u>&nbsp;DVP&nbsp;OPS+SUPPLY&nbsp;CHAIN&nbsp;</u><br>
&nbsp;<br>
Date: <u>&nbsp;2/1/22&nbsp;</u></td>
<td valign="top"><font style="font-size: 12pt; font-family: Times New Roman">NVE Corporation<br>
&nbsp;<br>&nbsp;<br>
By:&nbsp;<u>&nbsp;/s/&nbsp;DANIEL&nbsp;A.&nbsp;BAKER&nbsp;</u></font><br>
&nbsp;<br>
Name: <u>&nbsp;Daniel A. Baker&nbsp;</u><br>
&nbsp;<br>
Title: <u>&nbsp;President&nbsp;&amp;&nbsp;CEO&nbsp;</u><br>
&nbsp;<br>
Date: <u>&nbsp;2/1/22&nbsp;&nbsp;</u></td>
</tr>
</table>
<font style="font-size: 12pt; font-family: Times New Roman">&nbsp;<br>
&nbsp;<br>
&nbsp;<br></font>
<table border="0" cellspacing="0" cellpadding="0" width="100%">
<tr>
<td><font style="font-size: 12pt; font-family: Times New Roman">9025.3 -
NVE Corporation - Supply (Direct) Amended</font></td>
<td align="right"><font style="font-size: 12pt; font-family: Times New Roman">Page&nbsp;2&nbsp;of&nbsp;2</font></td>
</tr>
</table>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>nve-logo.gif
<DESCRIPTION>NVE CORPORATION LOGO
<TEXT>
begin 644 nve-logo.gif
M1TE&.#EA% $V +,   !&K0DW>0<C3$!.8GAY>O___^+BXK2TM
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MU_)%,+*=NCKJ)0UAF'57%7FR*J/NBF^\WLZ/K&KJ\K?1?<FQJM(7'2>Z\>A
M6Z^^U0$_=_9@A?J,2]0S^5?G[KV)=W.\!X[1Z>$OZ23KAVSY.J+<@R6\);7?
<W_[PN0-QO@E!Z%WBFM(PQNEH$ 9,H %1$P$ .P$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
